An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway by Shin, Hye-Won et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
 
©
 
 The Rockefeller University Press $8.00
The Journal of Cell Biology, Vol. 170, No. 4, August 15, 2005 607–618
http://www.jcb.org/cgi/doi/10.1083/jcb.200505128
 
JCB: ARTICLE
 
JCB 607
 
An enzymatic cascade of Rab5 effectors regulates 
phosphoinositide turnover in the endocytic pathway
 
Hye-Won Shin,
 
1
 
 Mitsuko Hayashi,
 
3
 
 Savvas Christoforidis,
 
2
 
 Sandra Lacas-Gervais,
 
4
 
 Sebastian Hoepfner,
 
1
 
 Markus R. Wenk,
 
3
 
 
Jan Modregger,
 
3
 
 Sandrine Uttenweiler-Joseph,
 
5
 
 Matthias Wilm,
 
5
 
 Arne Nystuen,
 
6
 
 Wayne N. Frankel,
 
6
 
 
Michele Solimena,
 
4
 
 Pietro De Camilli,
 
3
 
 and Marino Zerial
 
1
 
1
 
Max-Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany 
 
2
 
Laboratory of Biological Chemistry, Medical School, University of Ioannina, Ioannina 45110, Greece
 
3
 
Department of Cell Biology and Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510
 
4
 
Medical Theoretical Center, Medical School, University of Technology of Dresden, 01307 Dresden, Germany
 
5
 
European Molecular Biology Laboratory, 69117 Heidelberg, Germany
 
6
 
The Jackson Laboratory, Bar Harbor, ME 04609
 
eneration and turnover of phosphoinositides
(PIs) must be coordinated in a spatial- and
temporal-restricted manner. The small GTPase
Rab5 interacts with two PI 3-kinases, Vps34 and PI3K
 
 
 
,
suggesting that it regulates the production of 3-PIs at
various stages of the early endocytic pathway. Here, we
discovered that Rab5 also interacts directly with PI 5-
and PI 4-phosphatases and stimulates their activity. Rab5
regulates the production of phosphatidylinositol 3-phos-
phate (PtdIns[3]P) through a dual mechanism, by directly
phosphorylating phosphatidylinositol via Vps34 and by
a hierarchical enzymatic cascade of phosphoinositide-3-
kinase
 
 
 
 (PI3K
 
 
 
), PI 5-, and PI 4-phosphatases. The func-
G
 
tional importance of such an enzymatic pathway is dem-
onstrated by the inhibition of transferrin uptake upon
silencing of PI 4-phosphatase and studies in weeble mu-
tant mice, where deﬁciency of PI 4-phosphatase causes
an increase of PtdIns(3,4)P2 and a reduction in Ptd-
Ins(3)P. Activation of PI 3-kinase at the plasma mem-
brane is accompanied by the recruitment of Rab5, PI 4-,
and PI 5-phosphatases to the cell cortex. Our data pro-
vide the ﬁrst evidence for a dual role of a Rab GTPase in
regulating both generation and turnover of PIs via PI ki-
nases and phosphatases to coordinate signaling func-
tions with organelle homeostasis.
 
Introduction
 
Phosphoinositides (PIs) play a key role in fundamental cell
functions, such as signal transduction, cytoskeleton remodel-
ing, cell migration, and membrane trafficking (De Camilli et
al., 1996; Fruman et al., 1998; Katso et al., 2001). This multi-
functional role is due to cycles of phosphorylation and dephos-
phorylation at the 3, 4, and 5 positions of the inositol ring in
different subcellular compartments. Such process is catalyzed
by specific lipid modifying enzymes, PI kinases, and phos-
phatases, whose recruitment to the membrane and activity is
regulated in a temporal- and spatial-dependent manner (Odor-
izzi et al., 2000; Vanhaesebroeck et al., 2001; Wenk and De
Camilli, 2004). Small GTPases, such as Ras, Arf1, Arf6, Rho,
as well as Rab, are primary regulators of the recruitment and/or
activation of PI kinases (Rodriguez-Viciana et al., 1994; Godi
et al., 1999; Honda et al., 1999; Krauss et al., 2003; de Graaf et
al., 2004; Weernink et al., 2004). In the endocytic pathway,
Rab5 interacts directly with two distinct PI 3-Ks, type I PI 3-K
(p85
 
 
 
–p110
 
 
 
; PI3K
 
 
 
) and hVps34 (hVps34–p150; Christofo-
ridis et al., 1999b). The latter kinase is responsible for the gen-
eration of phosphatidylinositol 3-phosphate (PtdIns[3]P) on the
early endosome and the recruitment of a set of PtdIns(3)P bind-
ing Rab5 effectors such as EEA1 (Simonsen et al., 1998;
Christoforidis et al., 1999b).
Whereas PtdIns(4)P on the TGN and PtdIns(3)P on endo-
somes exert an essential housekeeping function in organelle
homeostasis and membrane transport, other PIs are produced in
response to a variety of extracellular stimuli. Phosphatidylino-
sitol 3,4-bisphosphate (PtdIns[3,4]P2) and phosphatidylinositol
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3,4,5-trisphosphate (PtdIns[3,4,5]P3) are produced by type I PI
3-K upon stimulation by growth factors or cytokines at the
plasma membrane, where they induce morphogenetic changes
via the reorganization of actin filaments (Vanhaesebroeck et
al., 2001). However, these PI species accumulate only tran-
siently. PtdIns(3,4,5)P3 peaks at 5–6 s after stimulation (Chung
et al., 2001) and is rapidly degraded upon phagocytosis and
macropinocytosis by PI phosphatases (Marshall et al., 2001;
Rupper et al., 2001; Funamoto et al., 2002). Similar to PI ki-
nases, PI phosphatases display exquisite substrate specificity.
For example, PI 3-phosphatases such as PTEN (Cantley and
Neel, 1999) dephosphorylate PtdIns(3,4,5)P3 to PtdIns(4,5)P2.
PI 5-phosphatases such as SHIP, synaptojanin, and type II PI
5-phosphatase, dephosphorylate either PtdIns(3,4,5)P3 or Ptd-
Ins(4,5)P2 or both, respectively (Vanhaesebroeck et al., 2001;
Mitchell et al., 2002). Two PI 4-phosphatases isoforms exist
(types I and II) each having two alternative splicing variants (
 
 
 
and 
 
 
 
), which preferentially dephosphorylate PtdIns(3,4)P2 to
PtdIns(3)P (Norris et al., 1995, 1997). The functional impor-
tance of PI kinases and phosphatases in PI metabolism is un-
derscored by the finding that mutations in genes encoding these
proteins are associated with hereditary disorders in humans and
induce severe developmental abnormalities in animal model
systems, particularly affecting neural function. For example,
the gene product deficient in the oculocerebrorenal syndrome
of Lowe (OCRL) is an inositol polyphosphate 5-phos-
phatase (Attree et al., 1992; Zhang et al., 1995) associated with
endosomes and Golgi membrane (Ungewickell et al., 2004;
Choudhury et al., 2005). A targeted mutation of mouse synapto-
janin-1 (Cremona et al., 1999) causes defects in vesicle traffick-
ing and actin dynamics at the synapse. Conditional knockout of
PTEN specifically in the brain induces severe alterations in the
cerebellum, with decreased cell proliferation and degeneration
of Purkinje cells in mice (Backman et al., 2001). The weeble
mutant mice bearing a mutation in the gene encoding type I PI
4-phosphatase are characterized by early postnatal neuronal
loss in the cerebellum and in the hippocampus, that ultimately
results in the death of homozygous animals 2–3 wk after birth
(Nystuen et al., 2001). Whereas the identification and charac-
terization of several PI kinases and phosphatases has greatly
advanced our understanding of the enzymology of PI metab-
olism, the mechanisms that coordinate the activity of these
enzymes to link PIs function and turnover remain largely un-
known. Here, we provide insights into this question through the
discovery of novel effectors of Rab5.
 
Results
 
Compartmentalization of PIs
 
Rab5 interacts with two distinct types of PI 3-K, PI3K
 
 
 
, and
hVps34 (Christoforidis et al., 1999b). To investigate whether
such interaction serves to regulate the synthesis of PtdIns(3)P
as well as other PIs in the early endocytic pathway we took ad-
vantage of the Rab5Q79L activated mutant, which causes the
expansion of early endosomes (Fig. 1 A). We examined the in-
tracellular localization of different PIs by expressing GFP
fused to various PIs-binding motifs. The 2XFYVE domain of
Hrs, which recognizes PtdIns(3)P (Gillooly et al., 2003), accu-
mulated on early endosomes (Fig. 1 A, 2XFYVE). In contrast,
even upon Rab5 activation the PH domain of Akt, a probe for
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 (Watton and Downward,
1999), localized to the plasma membrane in a polarized fashion
and no significant staining was observed on early endosomes
(Fig.1 A, Akt1[PH]). The PH domain of phosphatidylinositol
4-phosphate adaptor protein 1 (FAPP1), which recognizes Ptd-
Ins(4)P (Dowler et al., 2000), was mainly present on the Golgi
complex (Fig.1 A, FAPP1[PH]), where it colocalized with
 
  
 
-COP (Levine and Munro, 2002; De Matteis and Godi,
2004; unpublished data), whereas the PLC
 
 
 
 PH domain, which
binds PtdIns(4,5)P2 (Stauffer et al., 1998) was detected on the
plasma membrane and in the nucleus. Thus, among the PIs
tested, PtdIns(3)P is the only one that accumulates on early en-
dosomes bearing activated Rab5.
Early and recycling endosomes are structured as a mosaic
of subcompartments that harbour distinct Rab GTPases and
display a nonstochastic distribution (Sonnichsen et al., 2000).
We next investigated whether PtdIns(3)P is not only specifi-
cally concentrated in the Rab5 domain within the early endo-
Figure 1. PtdIns(3)P is enriched in the Rab5 domain. (A) NIH3T3 cells ex-
pressing Rab5(Q79L) and GFP-tagged 2XFYVE, Akt PH domain, FAPP1
PH domain, or PLC  PH domain were stained with antibodies against
Rab5 (4F11) followed by rhodamine-conjugated secondary antibodies.
Bar, 10  m. A431 cells were microinjected with myc-2XFYVE, CFP–Rab5,
and YFP–Rab4 (B) or myc–2XFYVE, YFP–Rab4, and CFP–Rab11 (D) and
stained with antibodies against myc (9E10) and Texas red–conjugated
secondary antibodies. The extent of colocalization between 2XFYVE,
Rab5, and Rab4 (C) or 2XFYVE, Rab4, and Rab11 (E) was quantified.
Colors in the histogram correspond to those used in the merge of double
or triple fluorescent signals in the panels. White arrows indicate positive
for 2XFYVE, Rab5, and Rab4. Green arrows indicate positive for Rab4
but negative for 2XFYVE and Rab5. Bar, 2  m. 
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somes (Gillooly et al., 2003) but also depleted from the other
Rab domains along the recycling pathway. Plasmids encoding
myc–2XFYVE, CFP–Rab5, and YFP–Rab4 or myc–2XFYVE,
YFP–Rab4, and CFP–Rab11 were microinjected in A431 cells
(Fig. 1, B and C or D and E) and the overlap between Rab5,
Rab4, and Rab11 and myc–2XFYVE was quantified (Fig. 1, C
and E), as previously described (Sonnichsen et al., 2000). The
2XFYVE fluorescent probe was expressed at levels that neither
caused the displacement of endogenous FYVE proteins such as
EEA1 (unpublished data), nor significantly affected the previ-
ously reported distribution of Rab5 and Rab4 domains (Son-
nichsen et al., 2000). More than 80% of 2XFYVE-positive
endosomes colocalized with Rab5. Rab4 was present in 
 
 
 
60%
of these structures, i.e., in the fraction of endosomes containing
both Rab5 and Rab4 but never Rab4 alone (Fig. 1 B, f, white
arrows; Sonnichsen et al., 2000). In contrast, only 20% of endo-
somes harbouring Rab11 or both Rab4 and Rab11 were positive
for myc–2XFYVE (Fig. 1 D). This fraction either corresponds to
the Rab5
 
 
 
Rab4
 
 
 
Rab11 triple-positive compartment (Sonnich-
sen et al., 2000) or to structures that cannot be resolved by light
microscopy techniques. These results suggest that PtdIns(3)P is
specifically enriched in the Rab5  domain of early endosomes.
 
Detection of PIs phosphatase activity in 
the Rab5 affinity column eluate
 
Despite the interaction of Rab5 with both PI3K
 
 
 
 and hVps34,
the morphological analysis described above suggests that a
mechanism must exist to efficiently segregate their products,
PtdIns(3,4,5)P3 and PtdIns(3,4)P2 on the plasma membrane
and PtdIns(3)P concentrated in a subdomain of the early endo-
somes. A clue to this mechanism came from the analysis of the
Rab5 effectors purified by affinity chromatography from bo-
vine brain cytosol on a GST–Rab5–GTP
 
 
 
S affinity column
(Christoforidis et al., 1999a). Measurements of PI enzymatic
activity of the Rab5 affinity column eluate (Fig. 2 A) were con-
sistent with the reported presence of two types of PI 3-Ks
(Christoforidis et al., 1999a). First, PtdIns(3)P was generated
from PtdIns in a reaction catalyzed by hVps34. Second, PI3K
 
 
 
generated PtdIns(3,4)P2 or PtdIns(3,4,5)P3 from PtdIns(4)P
and PtdIns(4,5)P2, respectively. Their activity was almost
abolished in the presence of 50 nM wortmannin (unpublished
data). Surprisingly, in addition to the aforementioned products,
additional PI species were generated when PtdIns(4)P and Ptd-
Ins(4,5)P2 were used as substrates (Fig. 2 A, asterisks). In the
presence of PtdIns(4)P, not only PtdIns(3,4)P2, but also Ptd-
Ins(3)P (Fig. 2 A, lane 2, asterisk) was detected. When Ptd-
Ins(4,5)P2 was used as substrate, in addition to the expected
PtdIns(3,4,5)P3, also PtdIns(3,4)P2 and PtdIns(3)P were gen-
erated (Fig. 2 A, lane 3, asterisks). All TLC spots were 3
 
 
 
-
phosphorylated PIs (3-PIs) as confirmed by HPLC analysis
after excision from the TLC plate (unpublished data). The most
straightforward explanation for such complex pattern of PIs is
that, in addition to the two PI 3-Ks, the Rab5 affinity column
eluate contains PtdIns(3,4,5)P3 5-phosphatase and PtdIns(3,4)P2
4-phosphatase activities. We thus performed PI 5-phosphatase
and 4-phosphatase activity assays using PtdIns(3,4,5)P3 and Ptd-
Ins(3,4)P2 
 
32
 
P-labeled substrates (see Materials and methods).
As shown in Fig. 2 B, PtdIns(3,4,5)P3 5-phosphatase and Ptd-
Ins(3,4)P2 4-phosphatase activities were indeed detected in the
column eluate from the Rab5–GTP
 
 
 
S but not the Rab5–GDP
affinity column. We therefore set out determine the identity of
such phosphatases.
 
Identification of PI phosphatases as new 
Rab5 effectors
 
The Rab5–GTP
 
 
 
S column eluate was fractionated by Super-
ose-6 gel filtration column chromatography (Christoforidis et
al., 1999a; Fig. 2 C) and the PtdIns(3,4,5)P3 5-phosphatase and
PtdIns(3,4)P2 4-phosphatase activities measured in every third
fraction (Fig. 2, D and E). The phosphatase assay was per-
formed in the presence of 50 nM wortmannin to inhibit the PI
3-K activity during the reaction. Peaks of PI 5- and 4-phos-
phatase activity were detected in fractions 26–29 and 34–36,
Figure 2. PI phosphatases activity in Rab5–GTP column eluate. (A) PI3-K
activity assay on eluates from GST–Rab5–GTP S affinity columns was
performed using PtdIns (PI), PtdIns(4)P (PI[4]P), or PtdIns(4,5)P2
(PI[4,5]P2) as substrates. Asterisks indicate extra product of 3 -phosphory-
lated PIs (see details in the Results section). (B) The PtdIns(3,4,5)P3 5-phos-
phatase or PtdIns(3,4)P2 4-phosphatase assay from eluates (15 or 5  l, re-
spectively) of GST–Rab5–GDP (gray bar) or GST–Rab5–GTP S (black
bar) affinity columns or buffer alone (white bar) was performed using 
32P-
labeled PtdIns(3,4,5)P3 or PtdIns(3,4)P2 as substrates (see Materials and
methods; data are representative of two independent experiments).
Higher amounts of Rab5 column eluate were required to measure the activ-
ity of PI 5-phosphatase compared with PI 4-phosphatase. (C) The eluate from
GST–Rab5–GTP S affinity column was separated using Superose 6 column
and fractions analyzed by SDS-PAGE followed by Coomassie staining (as-
terisks indicate sequenced phosphatases). (D and E) Every third fraction was
analyzed by either PtdIns(3,4,5)P3 5-phosphatase assay or PtdIns(3,4)P2
4-phosphatase assay. The phosphatase activity in peak fractions (fractions
25–29 and 34–36) was determined in two independent experiments. 
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respectively, and protein bands from SDS-PAGE of these frac-
tions were subjected to mass spectrometry sequencing. Among
these proteins, we identified a type II inositol 5-phosphatase
(5-Pase; Jefferson and Majerus, 1995) and a type I 
 
 
 
 Ptd-
Ins(3,4)P2 4-phosphatase (4-Pase; Norris et al., 1995). We
cloned the cDNAs encoding both phosphatases, expressed
them in Sf9 insect cells using the baculovirus system, purified
the recombinant proteins and raised corresponding polyclonal
antisera in rabbits. The antibodies against the 5- and 4-Pase de-
tected protein bands corresponding to the expected molecular
weight both in brain cytosol and selectively in the Rab5–GTP
 
 
 
S
eluate (Fig. 3, A and B) confirming the specificity of the activ-
ity assay (Fig. 2, D and E). The anti–5-Pase detected two bands
of 105 and 75 kD (Fig. 3 A, asterisks) that peptide sequencing
data confirmed to be the 5-Pase and most likely a degradation
product, respectively.
 
Direct and specific interaction between 
5- and 4-Pases and Rab5
 
The following three experiments demonstrated that both 5-
and 4-Pase interact with Rab5 directly and specifically. First,
we used a GST–Rab5 pull-down assay. Both recombinant 5-
and 4-Pases bound to beads containing GST–Rab5 preloaded
with GTP
 
 
 
S but not GDP (Fig. 3 C). Second, the specificity
of such interaction was verified using the yeast two-hybrid
system. Using the 
 
 
 
-galactosidase replica filter assay (Fig. 3,
D and E), blue colonies were obtained only upon cotransfor-
mation of prey plasmids (5- and 4-Pase) with bait vectors ex-
pressing wild-type Rab5 (WT)or activated Rab5 Q79L (QL)
but neither from dominant negative Rab5 S34N (SN), nor
Rab4 (WT, Q67L, S22N) transformants. Third, we tested the
ability of Rab5:GTP to recruit 5- and 4-Pase onto endosomes
in vivo. Whereas both endogenous and overexpressed 5- and
4-Pases were predominantly cytosolic, a fraction was re-
cruited onto the membrane of enlarged endosomes specifi-
cally upon coexpression of the activated Rab5 Q79L mutant
in HeLa cells (Fig. 3 F). Combined with the data of Fig. 2,
these results suggest that the 5- and 4-Pases interact in a GTP-
dependent manner, directly and specifically with Rab5 both
in vitro and in vivo.
 
Active Rab5 stimulates the catalytic 
activity of PI3K
 
 
 
, 5-, and 4-Pase in vitro
 
Rab5 interacts with three different enzymes that can be ordered
in a pathway to sequentially generate PtdIns(3,4,5)P3 from Ptd-
Ins(4,5)P2 (PI3K
 
 
 
) and subsequently dephosphorylate it to
PtdIns(3,4)P2 (5-Pase) and PtdIns(3)P (4-Pase). To test the hy-
pothesis that conversion of PtdIns(3,4,5)P3 into PI(3)P may in-
deed be regulated by Rab5, we first investigated whether the
interaction of 5- and 4-Pases or PI3K
 
 
 
 with this GTPase can
result in a stimulation of their enzymatic activity. Recombinant
5-Pase, PI3K
 
 
 
, or the Superose 6 fraction containing the 4-Pase
were incubated with recombinant Rab5 preloaded with GTP
 
 
 
S
or GDP before determining the corresponding enzymatic ac-
tivity. Nonprenylated Rab5 was used in this experiment as it
binds these enzymes in vitro (Christoforidis et al., 1999b). Ptd-
Ins(4,5)P2 was used as substrate for PI3K
 
 
 
 activity and 3
 
 
 
-
 
32
 
P-
labeled PtdIns(3,4,5)P3 or PtdIns(3,4)P2 as substrates for 5- or
4-Pase activity, as described above (Fig. 2 B). Rab5–GTP
 
 
 
S
but not Rab5–GDP dose dependently stimulated the activity of
PI3K
 
 
 
, 5-Pase, or 4-Pase (Fig. 4, A–C). We conclude that the
interaction with Rab5 stimulates the enzymatic activity of
PI3K
 
 
 
, 5-, and 4-Pases in vitro.
 
Rab5 modulates PtdIns(3)P production 
by two different mechanisms
 
These findings prompted us to determine whether Rab5 ac-
tively regulates the production of PtdIns(3)P on membranes.
To address this question, we used endosome enriched frac-
tions from HeLa cells, incubated these membranes with [
 
 
 
32
 
P]
cATP, in the presence or absence of either Rab5–GDI com-
plex or RabGDI alone (see Materials and methods). Lipids
were extracted, deacylated, and the PI isomers determined
by HPLC analysis. Addition of RabGDI, which efficiently
Figure 3. Identification of the 5- and 4-Pases and their direct and specific
interaction with Rab5 in vivo and in vitro. (A and B) Eluates from GST–
Rab5–GDP and GST–Rab5–GTP S affinity columns, bovine brain (bb)
cytosol, and membrane fractions were analyzed by Western blotting using
antibodies against 5- and 4-Pase. (C) Beads with GST–Rab5 preloaded
with GDP or GTP S were incubated with 5  g recombinant 5- or 4-Pases
bound proteins were eluted and, along with unbound material, analyzed
by Western blotting using anti–5- or 4-Pase antibodies. (D and E) L40p
cotransformants with LexA–Rab5 (WT), –Rab5Q79L (QL), –Rab5S34N
(SN), –Rab4 (WT), –Rab4Q67L (QL), or –Rab4S22N (SN) and either
pGAD10–5-Pase or –4-Pase were plated on WL dropout media and ana-
lyzed by  -galactosidase replica filter assay. (F) HA–5-Pase (a–c) or 4-Pase
(d–f) was coexpressed with Rab5(Q79L) or myc–Rab5(Q79L), respectively,
in HeLa cells with vaccinia virus expression system. Cells were fixed and
stained with antibodies against Rab5 (4F11) and HA (3F10) and then with
Alexa 488–conjugated anti–mouse and Texas red–conjugated anti–rat sec-
ondary antibodies (a–c) or with anti-myc (9E10) and 4-Pase antibodies and
then with Alexa 488–conjugated anti–mouse and rhodamine-conjugated
anti–rabbit secondary antibodies (d–f). Bar, 10  m. 
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extracted Rab5 from the membrane (Rubino et al., 2000), in-
hibited PtdIns(3)P synthesis approximately by 60% (Fig. 4
D, compare first bar with second bar). On the other hand, ad-
dition of the Rab5–GDI, complex which increases the frac-
tion of Rab5 on the membrane and the recruitment of its ef-
fectors (Rubino et al., 2000) stimulated the synthesis of
PtdIns(3)P more than 2.5-fold (Fig. 4 D, compare first bar
with third bar).
In principle, Rab5 can generate PtdIns(3)P directly
through phosphorylation of PI by hVps34. However, because
PI3K
 
 
 
, 5-, and 4-Pase are also Rab5 effectors, these three en-
zymes could be functionally linked in the generation of Ptd-
Ins(3)P from PtdIns(3,4,5)P3. To test this hypothesis, we
used function-blocking antibodies, as shown previously for
hVps34 (Siddhanta et al., 1998; Christoforidis et al., 1999b),
to specifically block the activity of the PI kinases or phos-
phatases in the in vitro assay. We succeeded in raising func-
tion-blocking antibodies against p110
 
 
 
 and 4-Pase (as deter-
mined using either recombinant proteins or the Rab5 affinity
column eluate as source of enzymes; see Materials and meth-
ods). Unfortunately, despite several attempts we could not ob-
tain blocking antibodies against the 5-Pase. The respective
affinity-purified antibodies blocked more than 80% of the
activity of PI3K
 
 
 
 (p85
 
 
 
–p110
 
 
 
) or 4-Pase in vitro (unpub-
lished data).
Anti-hVps34 function blocking antibodies reduced the
production of PtdIns(3)P in endosomal fractions by 70%,
consistent with previous results showing that Vps34 is re-
quired for the Rab5-dependent recruitment of EEA1 and early
endosome fusion (Siddhanta et al., 1998; Christoforidis et al.,
1999b; Hill et al., 2000; Fig. 4 E). Interestingly, anti-p110
 
 
 
function-blocking antibodies also reduced generation of Ptd-
Ins(3)P by 30%, and a comparable degree of inhibition was
obtained with anti–4-Pase antibodies (Fig. 4 E). The stimula-
tory effect of Rab5 on PtdIns(3)P production was also depen-
dent on PI3K
 
 
 
 (p85
 
 
 
–p110
 
 
 
) and 4-Pase. The concomitant
addition of anti-p110
 
 
 
 or anti–4-Pase to Rab5GDI complex
inhibited PtdIns(3)P by 30–40% (Fig. 4 D, compare third bar
with fourth and fifth bar), supporting the idea that PI3K
 
 
 
 and
4-Pase are downstream effectors of Rab5.
The simplest explanation of these results is that 30% of
the PtdIns(3)P production in these membrane fractions, which
contain early endosomes and some residual plasma membrane
fragments, is due to PI3K
 
 
 
 and to the sequential dephosphor-
ylation of PtdIns(3,4,5)P3 via 5- and 4-Pase activities. Given
the established activation of type I phosphoinositide-3-kinase
(PI3-K) at the plasma membrane (Stephens et al., 1993;
Fig.1), the presence of PI3-K
 
 
 
 on clathrin-coated vesicles
(Christoforidis et al., 1999b) and the enrichment of PI(3)P on
early endosomes (Gillooly et al., 2003), these results suggest
that Rab5 regulates the maintenance of a gradient of Ptd-
Ins(3)P from the plasma membrane to endosomal membranes
by a combination of direct synthesis and PtdIns(3,4,5)P3
dephosphorylation.
Figure 4. Rab5 regulates PI(3)P production with its effectors. (A–C) The
activity of recombinant protein of PI3K  (p85 –p110 , 150 nM) or 5-Pase
(25 nM) or 4-Pase fraction (1  l fraction 36) were analyzed with recombinant
Rab5–GDP or–GTP S in the presence of GDP (white bar) or GTP S (black
bar), as indicated. The concentration of recombinant Rab5 is indicated in
each bar. Bars indicate the stimulation of the enzymatic activity expressed in
arbitrary units relative to control (see Materials and methods) and each set
of data is representative from three independent experiments. Spot areas
were quantified by BAS3000 and correspond to the following PIs: (A) refers
to the spot area of PI(3,4,5)P3, (B) (PI[3,4]P2/[PI{3,4}P2 PI{3,4,5}P3]), (C)
(PI[3]P/[PI{3}P PI{3,4}P2]). (D) Endosomal fractions were incubated with
buffer, 150 nM Rab5–GDI complex alone, 150 nM Rab5–GDI with anti-
p110  or anti–4-Pase, or 5  M HIS–RabGDI in the presence of 100  M
GTP or GDP and [
32P]ATP for 5 min at 37 C. (E) Endosomal fractions were
incubated with IgG, anti-p110 , anti–4-Pase or anti-hVps34 function block-
ing Abs and [
32P]ATP for 5 min at 37 C. (D and E) Lipids were extracted,
deacylated, and analyzed by HPLC (see Materials and methods). Data are
means SD of two or three independent experiments.
Figure 5. Knockdown of 4-Pase decrease transferrin uptake. (A) Reduced
levels of 4-Pase 72 h after transfection of HeLa cells with siRNA, as detected
by Western blot. (B) Cells transfected with unspecific (diamonds) or 4-Pase–
specific (triangles) siRNA were allowed to internalize biotinylated transferrin
for the indicated times. The internalized transferrin was quantified as de-
scribed in Materials and methods, and standardized with respect to total
protein concentration of the lysate and expressed as percent of the amount
of internalized transferrin in control cells at t   40 min (n   4; mean   SD
of two independent experiments).JCB • VOLUME 170 • NUMBER 4 • 2005 612
Down-regulation of the 4- and 5-Pase 
inhibits transferrin uptake
We next explored the functional role of the 4-Pase in Rab5-
mediated endocytic transport, by measuring transferrin inter-
nalization. We established experimental conditions to knock-
down the 4-Pase using specific small interfering RNA (siRNA)
oligonucleotides. 72 h after transfecting the cells with the
siRNAs, we observed a dramatic reduction ( 70%) in 4-Pase
protein levels as evidenced by Western blot (Fig. 5 A). Strik-
ingly, we observed that knockdown of 4-Pase markedly in-
hibited transferrin internalization (Fig. 5 B). Silencing of the
5-Pase yielded a similar phenotype (unpublished data). These
results therefore suggest a requirement of 4- and 5-Pases for
Rab5-dependent receptor-mediated endocytosis.
Translocation of 4- and 5-Pase to cortical 
ruffles following serum stimulation
We next investigated whether the localization of endogenous
5- and 4-Pase were consistent with the aforementioned model.
To this aim we used primary cultures of astrocytes, as pilot
experiments revealed significant levels of both proteins in
these cells (Fig. 6). PtdIns(3,4,5)P3 production is strongly
stimulated by growth factors, which induce recruitment and ac-
tivation of PI 3-K to the plasma membrane (Stephens et al.,
1993). Thus, we examined the localization of 5- and 4-Pase
both in serum-starved cells and in starved cells exposed to se-
rum for 15 min. The 4-Pase and the 5-Pase were mainly diffuse
in the cytoplasm of serum-starved astrocytes (Fig. 6). How-
ever, upon serum stimulation, both enzymes translocated to the
cortical ruffles where they colocalized with the actin binding
protein cortactin and with a pool of Rab5 also recruited to the
cell surface (Fig. 6 A). The localization of Rab5 to the plasma
membrane is in good agreement with its participation in the
generation of membrane ruffles and lamellipodia (Spaargaren
and Bos, 1999; Lanzetti et al., 2004; unpublished data). Fur-
thermore, EEA1-positive early endosomes also accumulated
underneath the regions of the ruffling plasma membrane that
were enriched in the 5- and the 4-Pase (Fig. 6 B). However, the
two phosphatases did not accumulate on these structures al-
though we occasionally observed the presence of the 4-Pase
Figure 6. Localization of 5- and 4-Pase in cultured astrocytes. Cultured astrocytes starved overnight in serum-free medium were stimulated with 10% FCS-
containing medium for 15 min at 37 C, stained by immunofluorescence with rabbit polyclonal antibodies against 4- or 5-Pase (green), and counterstained
(red) with mouse antibodies directed against Rab5 (4F11) and cortactin or human autoantibodies directed against EEA1. Bars, 10  m.RAB5 REGULATES PHOSPHOINOSITIDE TURNOVER • SHIN ET AL. 613
(unpublished data). Thus, both 5- and 4-Pases colocalized pri-
marily with the cell surface but not the endosomal pool of
Rab5. These results indicate that, under stimulatory conditions,
the sites where PtdIns(3,4,5)P3 is generated (the plasma mem-
brane) and the cell compartment enriched in PtdIns(3)P (early
endosomes) are brought in close proximity of each other, and
that Rab5, the 5- and 4-Pase are also enriched at these sites.
These data support the hypothesis that a function of the enzy-
matic cascade controlled by Rab5 may be to rapidly and effi-
ciently convert newly generated PtdIns(3,4,5)P3 into PtdIns(3)P.
Functional consequences of loss of 
4-Pase in brain
To provide evidence for the importance of the 4-Pase in a
pathway leading to the generation of PtdIns(3)P in vivo, we
searched for potential alterations of PI metabolism in cells of
weeble mutant mice. Weeble mice carry a loss of function mu-
tation in the gene encoding the 4-Pase (Nystuen et al., 2001).
The 4-Pase was found to be present at the highest level in cer-
ebellar Purkinje cells (Fig. 7 B), where it had a diffuse distri-
bution throughout the cell body, dendrites, axons, and axon
terminals (Fig. 7, B and D; Fig. 7, F–H shows colocalization
of 4-Pase with the nerve termimal marker VAMP2–synapto-
brevin 2 in Purkinje cell nerve terminals in the deep cerebellar
nuclei). This result is consistent with high expression of 4-Pase
mRNA in Purkinje cells and with the finding that Purkinje cells
of the cerebellum are the most severely affected cell population
in the weeble mice brain (Nystuen et al., 2001). A qualitatively
similar immunostaining pattern, but of lower intensity, was ob-
served in cells of the hippocampus (Fig. 7 I). An even weaker,
but similar, staining pattern was observed in most other regions
of the brain (unpublished data). The staining was completely
absent in brain of weeble mice (Fig. 7, C, E, and J), indicating
that the antibody specifically detects the 4-Pase protein, as con-
firmed by Western blot analysis (Fig. 7 A).
We investigated whether the absence of 4-Pase in weeble
mutant mice produces changes in PI metabolism similar to
those caused by function-blocking antibodies in endosome-
enriched fractions (Fig. 4, D and E). First, we measured PI
phosphatase activities in cytosol extracts from wild-type (wt),
heterozygous, and homozygous weeble mutant mouse brains.
Fig. 7 K shows that PtdIns(3,4)P2 4-phosphatase activity was
specifically decreased in cytosol extracts from brain of weeble
compared with wt mice. Second, we measured the level of var-
ious PI species after metabolic labeling of primary cultures of
brain cells from wt and weeble mice. Given that immunofluo-
rescence analysis of primary cultures from mouse cerebral cor-
tices revealed significant expression of 4-Pase both in neurons
and glia (Fig. 6), we used primary cultures of astrocytes for fur-
ther experiments, as these cells grow very efficiently in vitro.
We compared levels of 3-PIs in serum-starved and se-
rum-stimulated wt and mutant cells. Cultured astrocytes were
metabolically labeled with [
3H]inositol for 48 h followed by
overnight incubation in serum-free medium in the continued
presence of [
3H]inositol. Cells were subsequently incubated in
the absence or presence of serum for 15 min at 37 C, after
which PIs were analyzed by HPLC. Strikingly, an approximate
twofold increase in the levels of PtdIns(3,4)P2 was observed in
astrocytes from weeble mice compared with cells from wt ani-
mals, under stimulated conditions (Fig. 7 L). Reduction in the
Figure 7. Immunohistochemistry and PIs analysis in
weeble mice. (A) Western blot for 4-Pase in  /  and
 /  mice and, as control, for  -tubulin. (B–J) Fluores-
cence microscopy analysis of 4-Pase on cerebellar and
brain sections from 12-d-old wt ( / ; B, D, F, and I) and
weeble ( / ; C, E, and J) mice. In  /  mice, 4-Pase
immunoreactivity was highly enriched in Purkinje cells
and present throughout their cell bodies and dendrites (B)
as well as axons and axon terminals in the deep cerebel-
lar nuclei (D). (F) 4-Pase positive (green) Purkinje cell
nerve terminals that outline the profile of a neuron in the
deep cerebellar nuclei were counterstained with anti-
VAMP2/synaptobrevins 2 antibodies (red). Green not
overlapping with red signal represent nonsynaptic por-
tions of Purkinje cell axons. (I) shows 4-Pase immunoreac-
tivity in the hippocampus of  /  mice. In  /  mice
there was no immunoreactivity for 4-Pase in either the
cerebellum (C and E), or the hippocampus (j). Bars: (A–I)
50  m; (insets) 25  m. ML, molecular layer; GL, granu-
lar layer; N, nucleus. (K) Production of free phosphate
was measured with mice brain cytosol in the presence of
the indicated substrates (see Materials and methods). The
PI(3,4)P2 phosphatase activity is specifically impaired in
the weeble mutant ( / ) mice. (L) Cultured astrocytes
were labeled with [
3H]myo-inositol and then incubated
with FCS-free ([
3H]myo-inositol containing) medium. After
the cells were stimulated with 10% FCS for 15 min at
37 C, total lipids were extracted and analyzed by HPLC.
Data show the percentages of fold increase compared
with the unstimulated wt astrocytes and are means   SD
of three independent experiments. The symbols indicate
the results of t test analysis; *, P   0.05, **, P   0.01
compared with the unstimulated wt astrocytes.JCB • VOLUME 170 • NUMBER 4 • 2005 614
levels of PtdIns(3,4,5)P3 in stimulated cells was also observed
(Fig. 7 L), possibly reflecting some compensatory feed-back
mechanisms. Consistent with the data of Fig. 4 (D and E), the
levels of PtdIns(3)P were also reduced under both resting and
stimulated conditions (27% and 28%, respectively; Fig. 7 L,
inset) in the cells lacking 4-Pase as compared with wt cells. Al-
together, these data indicate that the absence of 4-Pase specifi-
cally leads to an accumulation of PtdIns(3,4)P2 and a reduction
of PtdIns(3)P presumably due a defect of PtdIns(3,4,5)P3 turn-
over, in agreement with the measurements on HeLa cells in
vitro (Fig. 4 E).
Discussion
In this study we report that Rab5 coordinates a cascade of
PI enzymes including the two previously described PI 3-Ks
(hVps34 and PI3K ) and two new Rab5 effectors, the type II
inositol 5-Pase (Jefferson and Majerus, 1995) and the type I  
PtdIns(3,4)P2 4-Pase (Norris et al., 1995). Our data uncover a
mechanism whereby a single GTPase, Rab5, regulates both
synthesis and turnover of PIs through an enzymatic cascade of
effectors, thus coupling the function of PIs in signal transduc-
tion to the requirements of endocytic trafficking.
Rab5 regulates PI synthesis and 
turnover in the endocytic pathway
Rab5 regulates a complex network of effector proteins that are
recruited on the early endosome membrane by binding to Ptd-
Ins(3)P (Simonsen et al., 1998; Christoforidis et al., 1999b;
Nielsen et al., 2000; Schnatwinkel et al., 2004). PtdIns(3)P is
an important molecular hallmark of the endocytic pathway
(Wurmser and Emr, 1998). It is required for early endosome
fusion and motility along microtubules (Christoforidis et al.,
1999a; Hoepfner et al., 2005), phagosome maturation (Vieira et
al., 2001), multivesicular body formation (Futter et al., 2001),
and signaling (Tsukazaki et al., 1998). The findings that the
lipid kinase that generates PtdIns(3)P, hVps34, is also a Rab5
effector (Christoforidis et al., 1999b) and that the effectors
form large oligomeric complexes on the early endosome mem-
brane (McBride et al., 1999), led us to propose that Rab5 reg-
ulates the formation of a membrane domain on the early
endosome enriched in PtdIns(3)P and containing the various
effector proteins required for early endosome tethering, fusion,
and motility (Zerial and McBride, 2001). Our present results
strengthen this model with the demonstration that the synthesis
of PtdIns(3)P is regulated by Rab5 itself.
Among the PIs tested, PtdIns(3)P was the major 3-PI
present on early endosomes, despite the generation of other PI
species on the plasma membrane and a continuous membrane
flow toward the early endosomes. Furthermore, PtdIns(3)P is
enriched in the Rab5  domain and less abundant or absent from
other subcompartments of early and recycling (Rab4- and
Rab11-positive) endosomes. In addition to hVps34, Rab5 inter-
acts also with PI3K , a type I PI 3-K involved in the generation
of PtdIns(3,4,5)P3 and PtdIns(3,4)P2 upon stimulation at the
plasma membrane. Even in the presence of the constitutively
active Rab5Q79L mutant, PtdIns(3,4,5)P3 was localized to the
plasma membrane but not early endosomes, suggesting that
turnover of this PI must occur early to maintain the specificity
of PtdIns(3)P localization in the endosomal system. The dis-
covery that Rab5 interacts with, and stimulates the enzymatic
activity of, 5- and 4-Pase, provides an explanation for how
such synthesis and turnover can be coordinated.
We propose that the synthesis of PtdIns(3,4,5)P3 at the
plasma membrane is coupled either to the dephosphorylation of
the 3  position by PTEN, thus leading to PtdIns(4,5)P2, or to
the sequential dephosphorylation by 5- and 4-Pase, leading
to PtdIns(3)P. Such enzymatic cascade could initiate at the
plasma membrane, where under certain stimulatory conditions
pools of PtdIns(3)P can be detected (Maffucci et al., 2003), and
continue along transport to the early endosomes, given that
PI3K  is detected in clathrin-coated vesicles (Christoforidis et
al., 1999b), presumably until PtdIns(3,4,5)P3 and PtdIns(3,4)P2
are depleted. Other 5-phosphatases, in particular SHIP, that
prefers PtdIns(3,4,5)P3 as a substrate, may cooperate with
5-Pase in the first of the two dephosphorylation reactions. This
model is consistent with a study by Ivetac et al. (2005), pub-
lished while this manuscript was in revision, that reported the
association of 4-Pase with early and recycling endosomes in
COS-1 cells.
Interestingly, the 5-Pase was identified in a search for Ptd-
Ins(3,4,5)P3-binding proteins (Krugmann et al., 2002) and the
4-Pase was recovered in a complex with PI3-K (Munday et al.,
1999) and binds PtdIns(3,4)P2 via its C2 domains (Ivetac et al.,
2005). These observations raise the interesting possibility that,
at the plasma membrane, Rab5 may regulate the recruitment of
various effectors by a combinatorial principle similar to the one
operating on early endosomes. Whereas on early endosomes
Rab5 regulates the recruitment of FYVE proteins (e.g., EEA1)
in combination with PtdIns(3)P, at the plasma membrane it
may cooperate with PtdIns(3,4,5)P3 in the recruitment of other
effector proteins. Specifically, activated Rab5 would bind and
stimulate PI3K  activity, thus eliciting in a positive feedback
mechanism the production of its “co-receptor” PtdIns(3,4,5)P3.
Both Rab5 and PtdIns(3,4,5)P3 would then serve as binding
sites to recruit the 5-Pase, resulting in dephosphorylation of
PtdIns(3,4,5)P3 to PtdIns(3,4)P2. PtdIns(3,4)P2 would then re-
cruit the 4-Pase, which, activated by Rab5-GTP, would de-
phosphorylate PtdIns(3,4)P2 to PtdIns(3)P.
The extent to which such enzymatic cascade operates
along the pathway probably depends on cell type and growth
conditions. Under steady-state, it may contribute only a lesser
( 30%) fraction of PtdIns(3)P production in comparison with
direct phosphorylation of PtdIns by hVps34. However, it may
constitute an important regulatory system ensuring endocytic
transport and organelle homeostasis under various PI 3-K–
dependent signaling conditions. Rab5 itself is activated both at
the plasma membrane and on EEA1-positive early endosomes
upon EGF stimulation (Di Fiore and De Camilli, 2001). The
stimulatory activity of Rab5 on PI3K  could thus contribute to
the generation of 3-PIs at the cell surface in response to various
signals, thus inducing morphogenetic changes (Spaargaren and
Bos, 1999; Lanzetti et al., 2004). The finding that both 5- and
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rum stimulation (this study and Ivetac et al., 2005) strongly
supports the view that the PtdIns(3,4,5)P3 produced is sub-
jected to Rab5-regulated turnover to restrict it to the plasma
membrane and to restore the production of PtdIns(3)P before,
or at arrival into, the early endosomes that accumulate under-
neath the ruffling region. This mechanism must operate with
high efficiency early in the pathway as both 5- and 4-Pase
do not accumulate on early endosomes (Fig. 6), and Ptd-
Ins(3,4,5)P3 and PtdIns(3,4)P2 could not be detected on this
compartment (Fig. 1). Accordingly, PtdIns(3,4,5)P3 was ob-
served in the phagocytic cup (Marshall et al., 2001) but not on
phagosomes, which were instead enriched in PtdIns(3)P (Vie-
ira et al., 2001). In addition, Rab5 may regulate the activity of
other PI Pases, as we have recently detected the inositol poly-
phosphate 5-phosphatase OCRL (Attree et al., 1992; Zhang et
al., 1995) in the eluate from the Rab5 affinity column (un-
published data). By converting PtdIns(4,5)P2 into PtdIns(4)P,
OCRL may contribute to the Rab5-dependent regulation of PIs
on endosomal receptor trafficking and sorting (Ungewickell et
al., 2004; Choudhury et al., 2005).
Although dephosphorylation at the 3  position of the
inositol ring by PI 3-Pases such as PTEN (Leslie and Downes,
2002) may contribute to termination of PI(3,4,5)P3 signaling, a
distinguished feature of the enzymatic cascade described in this
study is the generation of other 3-PIs that have signaling func-
tions of their own. Unlike Ivetac et al. (2005), we could not
consistently observe endosomal abnormalities in HeLa cells
lacking 4-Pase or primary cultures of weeble neurons (unpub-
lished data). The expression of inositol 4-phosphatase type II
may partially compensate for the lack of 4-Pase (the type I iso-
form; Majerus et al., 1999) and the presence of Vps34 ensures
the bulk of production of PtdIns(3)P. However, unexpectedly
we could detect alterations in receptor-mediated endocytosis.
Because inhibition of PI3-K with wortmannin does not dramat-
ically impair transferrin internalization (Martys et al., 1996;
Shpetner et al., 1996; Spiro et al., 1996), it is plausible that the
accumulation of PtdIns(3,4,5)P3 and PI(3,4)P2 rather than re-
duced production of PI(3)P on endosomes by 4-Pase RNAi
may exert an inhibitory effect on the endocytic process.
Unbalance in PI metabolism and neuronal 
degeneration in 4-Pase–deficient mice
That the aforementioned turnover of PIs is of high physiological
importance is underscored by the phenotypic analysis of weeble
mutant mice (Nystuen et al., 2001). When we inspected the PIs
levels in cultured astrocytes of weeble mice, we detected an
enhancement of PtdIns(3,4)P2 as well as significant ( 30%)
reduction in PtdIns(3)P, under both resting and stimulatory
conditions. These data are consistent with the measurements
on PI synthesis on HeLa membrane fractions in vitro and the
view that dephosphorylation of PtdIns(3,4,5)P3 to PtdIns(3)P
is impaired in weeble mutants due to a selective block of the
4-Pase reaction.
The precise mechanism leading to early neuronal loss in
weeble mutant mice remain to be established. We suggest that
impaired PtdIns(3,4)P2 dephosphorylation may cause an im-
balance in both signaling and endocytosis due to excess Ptd-
Ins(3,4)P2 signaling, lowered PtdIns(3)P production or both.
Several scenarios, including the ones listed below, can be hy-
pothesized to explain neuronal death.
First, abnormal PI signaling may affect the balance be-
tween factors that promote cell survival and cell death. During
postnatal neural development, cell proliferation, apoptosis, and
differentiation are regulated by complex and accurately orches-
trated signaling pathways, triggered by various neurotrophic
factors (Segal and Greenberg, 1996). PIs play an essential role
in these processes (Fruman et al., 1998) and the unbalance in PI
turnover, primarily the accumulation of PtdIns(3,4)P2, may
have important disrupting effects of growth factor receptor sig-
naling. For example, neurons that are forced to reenter the cell
cycle by an expressed oncogene undergo apoptosis rather than
divide (Feddersen et al., 1992).
Second, the endocytic alterations due to loss of 4-Pase may
produce directly or indirectly an impact on neuronal function. For
example, a chronic impairment in glutamate receptor endocyto-
sis may lead to excess excitatory signaling with resulting cell
death (Garthwaite and Garthwaite, 1991; Doughty et al., 2000).
Third, as 4-Pase can also act on inositol polyphosphates
(Norris et al., 1995, 1997; Majerus et al., 1999), actions me-
diated by abnormal metabolic flux through the various ino-
sitol polyphosphate metabolites cannot be excluded. Besides
Ins(1,4,5)P3, which controls Ca
2  signaling, inositol polyphos-
phates also have important effects on nuclear function (Steger
et al., 2003; York, 2003).
In conclusion, our data underscore the importance of en-
zymatic networks regulating PI synthesis and turnover to co-
ordinate both signaling and trafficking functions. The Rab5
network of PI kinases and phosphatases appears to be funda-
mental under stimulatory conditions, particularly during mat-
uration of the nervous system. It will be important to further
elucidate how Rab5 and its effectors may actively participate
in signal transduction in neurons and other highly differenti-
ated cell types.
Materials and methods
Reagents and cell lines
Phospholipids were purchased from Sigma-Aldrich, [ -
32P]ATP from Amer-
sham Biosciences, and Silica Gel 60 TLC plates (20   20 cm) from
Merck. [
3H]PtdIns, [
3H]PtdIns(4)P, and [
3H]PtdIns(4,5)P2 were purchased
from NEN Life Science Products. Most HPLC grade organic chemicals and
water were purchased from Fluka or Merck. GST–p85  baculovirus was
a gift of Dr. Waterfield (Ludwig Institute for Cancer Research, London,
UK), the polyclonal human anti-EEA1 antibody, GFP-2XFYVE (Hrs) and
myc-2XFYVE plasmids of Dr. Stenmark (Norwegian Radium Hospital,
Oslo, Norway). A431, NIH3T3, HeLa cells, and astrocytes from weeble
mice were cultured under standard conditions.
Antibodies and plasmids
Anti-p110  or hVps34 function blocking antibodies were raised against
synthetic peptides (C)KVNWMAHTVRKDYRS or AVVEQIHKFAQYWRK
(Siddhanta et al., 1998; Hill et al., 2000) and anti-5 or -4 Pase antibodies
against recombinant full length proteins (see Preparation of recombinant
PI3K , 5-Pase, 4-Pase, and Rab5). The affinity-purified anti-p110  and
anti–4-Pase antibodies blocked  80% activity of the recombinant proteins
in 1:2 or 1:4 antigen/antibody molar ratio. Anti-hVps34 antibody was
used as previously reported (Siddhanta et al., 1998; Christoforidis et al.,
1999b). Mouse monoclonal antibody against Rab5a was 4F11, monoclo-
nal mouse anti-cortactin, and rat anti-HA (3F10) antibodies, and HRP- andJCB • VOLUME 170 • NUMBER 4 • 2005 616
fluorescent-conjugated secondary antibodies were purchased from Up-
state Biotechnology, Roche, Dianova, and Molecular Probes, respectively.
The human cDNA encoding human p110 , a gift of Dr. Maier
(Freie University, Berlin, Germany), was subcloned into modified baculovi-
rus expression vector pFastBacGST. The human cDNAs encoding 5- and
4-Pase obtained by RT-PCR were subcloned into pcDNA3 (Invitrogen),
pGAD10, and pFastBacGST. Plasmids expressing ECFP- and EYFP-tagged
Rab and Rab5Q79L were as previously described (Stenmark et al., 1994;
Sonnichsen et al., 2000). cDNAs encoding the PH domain of human Akt
was cloned by RT-PCR and mouse PLC , human FAPP1 were purchased
from IMAGE consortium and subcloned into EGFP-c3 vectors (Clontech).
Yeast two-hybrid and pull down assay
Yeast transformation and two-hybrid analysis were performed according
to the MATCHMAKER instructions (Clontech). In brief, a yeast strain L40
was cotransformed with a pLexA-based bait vector and a pGAD10-based
prey vector and plated on a medium lacking Trp and Leu. After 2–3 d of
incubation colonies were tested for  -galactosidase activity by the replica
filter assay. GST–Rab5 pull-down assay using recombinant 5- and 4-Pase
proteins (5  g each) was performed as previously described (Christofori-
dis et al., 1999a).
Cell transfection, microinjection, and immunofluorescence analysis
Plasmids were transfected to NIH3T3 cells with FuGENE6 (Roche). Expres-
sion of proteins in HeLa cells grown to 60% confluence using the T7 RNA
polymerase recombinant vaccinia virus was as in (Stenmark et al., 1994).
For the colocalization of 2XFYVE with Rab proteins, a mixture of 50
ng/ l plasmid DNA for myc-2XFYVE, EYFP-Rab4, and ECFP-Rab5 or
ECFP-Rab11 was injected into the nucleus of A431 cells with an Eppen-
dorf micromanipulator and transjector. Immunofluorescence analysis (Sten-
mark et al., 1994) was performed using an LSM 510 station confocal mi-
croscope (Carl Zeiss MicroImaging, Inc.). Quantification of colocalization
was performed as in Sonnichsen et al. (2000).
Cultured astrocytes serum-starved overnight were incubated in
MEM with or without 10% FCS for 15 min at 37 C, fixed in 4% PFA in
phosphate buffer, and then stained by immunofluorescence by standard
procedures. Primary antibodies were visualized with goat anti–rabbit
IgGs conjugated to Oregon green, anti–mouse IgGs conjugated to Alexa
594, and anti–human IgGs conjugated to Texas red.
Immunohistochemistry of brain sections
Weeble mice and wt 12- or 19-d-old littermates were fixed by transcar-
diac perfusion with 1% PFA in 120 mM sodium phosphate buffer. Brains
were collected, fixed for an additional 3 h in the same solution, cryopro-
tected by infiltration with sucrose 30%, and frozen. 12- m cryostat sec-
tions were immunolabeled as previously described (De Camilli et al.,
1983) with rabbit anti–4-Pase antibodies and monoclonal antibodies to
VAMP2-synaptobrevin 2 (Synaptic Systems). Goat anti–rabbit IgGs conju-
gated to Alexa 568 or Oregon green and goat anti–mouse IgGs conju-
gated to Texas red were used as secondary antibodies.
Preparation of recombinant PI3K , 5-Pase, 4-Pase, and Rab5
Recombinant Pases were expressed as GST-tagged proteins in High Five
insect cells according to the manufacturer’s instructions (BD Biosciences)
with the use of pFAST Bac GST-5-Pase or GST-4-Pase. To produce re-
combinant p85 –p110  complex, High Five cells were coinfected with
GST-tagged p85  and untagged p110  baculoviruses, and the proteins
purified by a single-step on a glutathione–agarose column followed by
cleavage of GST with Precission protease (GE Healthcare). Recombinant
GST–Rab5 was purified as previously described (Christoforidis et al.,
1999a) and GST was cleaved with Factor Xa.
PI 3-K activity assay
PI 3-K activity in the GST–Rab5/GTP S column eluate of bovine brain cy-
tosol (Christoforidis et al., 1999a) or by recombinant PI3K  was assayed
in buffer containing PtdIns (0.2 mg/ml), PtdIns(4)P (0.2 mg/ml), or Ptd-
Ins(4,5)P2 (0.23 mg/ml) in 50  l of 20 mM Hepes, pH 7.4, 1 mM
EGTA, 5 mM MgCl2, 50  M ATP, 10  Ci [ 
32P]ATP, 0.23 mg/ml phos-
phatidylserine, 0.2 mM adenosine. The reaction was run for 10 min at
37 C (unless stated) and arrested with 50  l of 1 N HCl, extracted with
100  l of CHCl3/MeOH (1:1) and washed twice with 1 N HCl/MeOH
(1:1). Dried lipids were resuspended in 15  l of CHCl3/MeOH/H2O (75:
25:2, vol/vol/vol), separated by TLC using CHCl3/acetone/MeOH/gla-
cial acetic actid/H2O (80:30:26:24:14,vol/vol/vol/vol/vol), analyzed
using BAS3000 bioimaging analyzer (Fuji) and the corresponding spots
were quantified by Image Guage software (Fuji). TLC plates were pre-
treated with (1% potassium oxalate/2 mM EDTA)/MeOH (1:1, vol/vol)
and dried overnight.
Production of 
32P-labeled PIs and Pase activity assay
Recombinant PI3K  (p85 /p110 ) was used to produce [
32P]PtdIns(3,4)P2
and [
32P]PtdIns(3,4,5)P3 using the described methods above. The mixture
of PtdIns(4)P/[
32P]PtdIns(3,4)P2 or PtdIns(4,5)P2/[
32P]PtdIns(3,4,5)P3 was
then extracted, dried under nitrogen, and stored at  20 C. Dried [
32P]Ptd-
Ins(3,4)P2 were dissolved in 50 mM MOPS, pH 6.8, 200 mM NaCl,
0.3%  -octylglucoside for 4-Pase activity and [
32P]PtdIns(3,4,5)P3 in 20
mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM MgCl2, 0.3%  -octylglucoside
for 5-Pase activity assays by sonication. The assay was started upon addi-
tion of either GST–Rab5 column eluate or recombinant phosphatases, incu-
bated for 5 min at 37 C and the reaction was blocked by addition of 1 M
HCl. Upon extraction the inositol lipids were then separated by TLC and
quantified, as described above. The 5- and 4-Pase activities were calcu-
lated as PtdIns(3,4)P2/(PtdIns[3,4]P2 PtdIns[3,4,5]P3) or PtdIns(3)P/(Ptd-
Ins[3]P PtdIns[3,4]P2) ratio, respectively.
For phosphate release assay, the cytosolic protein preparations
were obtained by homogenization of brains from 10-d-old mice in 25 mM
Tris, pH 8.0, 250 mM sucrose, 500 mM KCl, 10 mM MgCl2, 2 mM
EGTA, 1 mM DTT containing Complete Mini, EDTA-free protease inhibitor
cocktail (Roche Applied Sciences). Homogenates were ultrafuged 45 min
at 50,000 rpm at 4 C in a TLA 100.2 rotor (Beckman Coulter). Superna-
tants were passed over NAP 5 columns (Amersham Biosciences) and
eluted with 30 mM Hepes, pH 7.4, 1 mM EGTA, 1 mM MgCl2, and 100
mM KCl. Two independent wt, heterozygous, and knock out mice were as-
sayed in triplicate with and without addition of synthetic PIs (Echelon Re-
search Laboratories). Production of free phosphate was assayed as de-
scribed previously (Harder et al., 1994). 5–10  g cytosol protein were
incubated with 1  g lipid substrate for 10–30 min at 37 C. Free Pi gener-
ated was measured by malachite green assay using a microplate reader
at 620 nm. Data were corrected for background activity by subtracting
 PIP absorbance from  PIP absorbance for each reaction.
Analysis of [
32P]PIs production in isolated endosomes
Endosome fractions (20  g) prepared as described by Gorvel et al.
(1991) were incubated in reaction buffer (50  l of 20 mM Hepes, pH
7.4, 1 mM EGTA, 5 mM MgCl2, 5 mM MnCl2, 20  M ATP, 70  Ci
[ 
32P]ATP) for 5 min at 37 C. The membrane fraction was incubated with
50  M GTP and purified 164 nM of Rab5–GDI complex, 50  M GDP,
and 10  M of His–RabGDI from Escherichia coli (Ullrich et al., 1995) or
preincubated with IgG or affinity purified anti-p110  or anti–4-Pase Ab.
The reaction was arrested by adding 50  l of 1 N HCl and lipids were ex-
tracted, dried under nitrogen gas, and stored at  20 C until use. To isolate
PI isomers, [
32P]phospholipids mixture was deacylated and analyzed by
anion exchange PartiSphere 5 SAX column (Whatman) connected to
HPLC (Waters 2690) and radioactive detector (Biostep) according to Se-
runian et al. (1991). Relevant peaks were identified by coelution with
commercially available 
3H-labeled standards or by comparing with the re-
tention time of 3 -
32P-labeled products from PI3-K assay as described
above. The recorded peak by radioactive detector was calculated as a
peak area by Millenium software (Waters) or the radioactivity in each
fraction counted by  -scintillation.
Metabolic labeling of cultured astrocytes
Cultured astrocytes were incubated with [
3H]myo-inositol (20  Ci/ml) for
48 h in medium containing FCS and subsequently starved with FCS-free
([
3H]myo-inositol–containing) medium overnight at 37 C. Cells were then
stimulated with 10% FCS for 15 min at 37 C. Total lipids were extracted
by adding 50% MeOH/1 M HCl and chloroform, deacylated, and ana-
lyzed by HPLC according to Serunian et al. (1991). Radioactivity was as-
sayed with an on-line counter (Packard). Peaks were identified using inter-
nal standards (Cremona et al., 1999; Nemoto et al., 2000).
siRNA tranfection and biotinylated transferrin internalization
Duplex siRNA (4-Pase: 5 -GGAAAUAUACAAGACCCAGTT and 5 -
CUGGGUCUUGUAUAUUUCCTG; 5-Pase: 5 -CGCUCUCUUCCUCUAU-
ACGTT and 5 -CGUAUAGAGGAAGAGAGCGTG) were purchased
from Ambion. For the transferrin internalization assay, HeLa cells were
transfected with specific siRNAs for various phosphatases or GFP (mock)
using oligofectamine (Invitrogen). At 72 h (siRNA) after transfection, cells
were starved for 2 h in CO2-independent DME medium containing
0.2% BSA and then allowed to internalize biotinylated transferrin (10
 g/ml) for the indicated times. Cells were placed on ice, washed, lysed,
and the total cell extract was incubated with affinity-purified, Ruthenium-RAB5 REGULATES PHOSPHOINOSITIDE TURNOVER • SHIN ET AL. 617
labeled, sheep anti–human transferrin antibodies (SAPU) and subse-
quently analyzed using an ECL-Analyser System from Igen Inc.
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